Home > Products > Chemicals > Pharmaceutical Chemicals > Pharmaceutical Intermediates (28744)
Language Option more
Check out all Product Listings for Cephalomannine
Related Searches: Cephalomannine alarm security system 600d shopping bag 2v battery

Cephalomannine,Pharmaceutical Intermediates

Place of Origin: China (Mainland)
CAS No.: 71610-00-9
Payment Terms: L/C,T/T
Minimum Order Quantity: 1 Kilogram
Package: Package: al bag and al tin
Click to send an inquiry

Product Details

Pharmaceutical Intermediates
Cephalomannine
It is most commonly used to treat ovarian, breast ,non-small cell lung cancer
Pharmaceutical Intermediates 

CEPHALOMANNINE is another active compound obtained from the yew tree. It has been used in the research and development of new anti-cancer agents. It is a chemotherapy drug that is given as a treatment for some types of cancer. It is commonly known as Taxol. It is most commonly used to treat , and non-small cell . This information describes paclitaxel, how it is given and some of its possible side effects. It should ideally be read with our general information about and about your cancer, which give further information and advice.

Specifications

 

CAS: 71610-00-9
Molecular Formula: C45H53NO14 
Molecular Weight: 831.9 
Content: no less than 80%                                                                                  Appearance White or almost white power
Identification Confirm
Moisture <1.0%
Chromatographic Impurities Total impurities <1.0%
Purity >99.0%

Appearance

 White crystalline powder

Water (by KF) ≤1.0%

Arsnic ≤2 ppm

Heavy metals ≤5 ppm

Specific Optical Rotation -48.0°-56.0°

Melting point 215.0217.0

Package:  al bag and al tin

Send your message to this supplier

Cephalomannine,Pharmaceutical Intermediates
Pharmaceutical Intermediates Cephalomannine It is most commonly used to treat ovarian, breast ,non-small cell lung cancer
Min. Order: 1 Kilogram

Let supplier know exactly what you're looking for Post Buying Leads Now!

View More Related Items

Email this page Bookmark this page Print this Page